Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1997
03/04/1997US5607847 Cells, monoclonal antibodies and hybridomas
03/04/1997US5607846 Vaccine for moraxella catarrhalis
03/04/1997US5607840 Protein hydrolysate derived from mucosa tissue
03/04/1997CA2129824C Mutant interleukin 6 with improved biological activity over wild interleukin 6
03/04/1997CA2067797C Production and use of human nm23 protein and antibodies therefor
03/04/1997CA2058971C Efficient method for identifiable expression of non-selectable genes
03/01/1997CA2184301A1 Bacillus thuringiensis sporulation gene
02/1997
02/27/1997WO1997007404A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression
02/27/1997WO1997007232A1 Antigenic preparations
02/27/1997WO1997007216A1 Deuteriated substances
02/27/1997WO1997007206A1 Method for preparing polypeptide variants
02/27/1997WO1997007205A1 Method for preparing polypeptide variants
02/27/1997WO1997007204A1 Antibody 105a5 to 'peanut agglutinin' (pna)-binding glycoprotein on cell surfaces
02/27/1997WO1997007198A2 Dna sequences and secreted proteins encoded thereby
02/27/1997WO1997007135A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
02/27/1997WO1997007134A1 Traf inhibitors
02/27/1997WO1997007132A1 Epitope tagging system
02/27/1997WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same
02/27/1997WO1997006821A1 Heat shock protein-based vaccines and immunotherapies
02/27/1997WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same
02/27/1997WO1997004005A3 Cyclosporin derivatives with anti-hiv effect
02/27/1997WO1996040885A3 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION
02/27/1997DE19531033A1 Antikörper gegen an Oberflächen von Carcinom-Zellen außerhalb von Desmosomen exponierte Epitope desmosomaler Cadherine Antibodies against at surfaces of carcinoma cells outside exposed epitopes of desmosomal cadherins of desmosomes
02/27/1997CA2230051A1 Deuteriated substances
02/27/1997CA2229938A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression
02/27/1997CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same
02/27/1997CA2229557A1 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
02/27/1997CA2229543A1 Heat shock protein-based vaccines and immunotherapies
02/27/1997CA2229540A1 Epitope tagging system
02/27/1997CA2229208A1 Dna sequences and secreted proteins encoded thereby
02/27/1997CA2227174A1 Traf inhibitors
02/26/1997EP0759469A1 Bacteriocin
02/26/1997EP0759468A1 Feline interleukin-4
02/26/1997EP0759466A2 Low binding affinity interleukin-12 beta receptors
02/26/1997EP0759465A1 Gene imparting flocculability to yeast and gene product
02/26/1997EP0759442A1 Tumor immunotherapy using anti-idiotypic antibodies
02/26/1997EP0759302A1 Remedy for rheumatoid arthritis
02/26/1997EP0759170A1 Uses of green fluorescent protein
02/26/1997EP0759086A1 Method of introducing pathogen resistance in plants
02/26/1997EP0759084A1 Complex inducible promoter system derivable from a phage of a lactic acid bacterium (lab), and its use in a lab for production of a desired protein
02/26/1997EP0759082A1 Dna construct for effecting homologous recombination and uses thereof
02/26/1997EP0759081A1 Glucan-binding proteins, and use thereof
02/26/1997EP0759078A1 Genes for the synthesis of antipathogenic substances
02/26/1997EP0759077A1 Lanthionine-containing antimicrobial compound
02/26/1997EP0759075A1 Apoptosis regulating gene
02/26/1997EP0759073A1 AN ENZYME WITH ENDO-1,3(4)-$g(b)-GLUCANASE ACTIVITY
02/26/1997EP0759072A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
02/26/1997EP0759071A1 Wt1 monoclonal antibodies and methods of use therefor
02/26/1997EP0759068A1 $i(RPS2) GENE AND USES THEREOF
02/26/1997EP0759067A1 Transforming growth factor alpha h1
02/26/1997EP0759036A1 Immunointeractive molecules-i
02/26/1997EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
02/26/1997EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
02/26/1997EP0651824A4 Transcription control element for increasing gene expression in myoblasts.
02/26/1997EP0570554A4 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state
02/26/1997EP0541753B1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT
02/26/1997CN1143978A Antimicrobial proteins from aralia and impatiens
02/26/1997CN1143967A Method for variation of chromatin condensation
02/26/1997CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r
02/25/1997US5606043 Methods for the diagnosis of glaucoma
02/25/1997US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification
02/25/1997US5606031 Expressing gene coding for neurotrophic factor in bacteria, solubilizing, sulfonylating, isolating and purifying by anion exchange chromatography, allowing to refold, purifying by cation exchange chromatography
02/25/1997US5606024 Canine G-CSF polypeptides and pharmaceutical compositions comprising same
02/25/1997US5606022 Cloning and identification of a two component signal transducing regulatory system from Bacteroides fragilis
02/25/1997US5606021 Mineralocorticoid receptor compositions and methods
02/25/1997US5606019 Synthetic proteins having alternating blocks of fibroin and elastin repeating units; bioresorbable
02/25/1997US5605886 Anti-obesity proteins
02/25/1997US5605825 Human PAK65
02/25/1997US5605821 Expression control sequences of the P-selectin gene
02/25/1997US5605817 DNA encoding chemokine expressed in fetal spleen
02/25/1997US5605814 DNA encoding human prostaglandin receptor EP2
02/25/1997US5605808 Oncoprotein protein kinase
02/25/1997US5605804 Monitoring course of disease in patient by performing series of immunoassays over time to determine changes in level of nonspecific crosssreacting antigen 50/90 in blood samples
02/25/1997US5605803 Human sperm diagnostic
02/25/1997US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites
02/25/1997US5605793 Adding to cleaved random double stranded fragments one or more single stranded or double stranded oligonucleotides, denaturing into single stranded fragments, incubating
02/25/1997US5605692 Polypeptide
02/25/1997US5605689 Treatment of HIV-associated immune thrombocytopenic purpura
02/25/1997US5605688 Recombinant dog and horse type I interferons
02/20/1997WO1997006274A1 Composition and its use
02/20/1997WO1997006265A2 Recombinant clone selection system
02/20/1997WO1997006256A2 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
02/20/1997WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
02/20/1997WO1997006254A1 Human mp52 arg protein
02/20/1997WO1997002730A3 Enamel matrix related polypeptide
02/20/1997WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells
02/20/1997CA2512366A1 Mammalian iap gene family, primers, probes and detection methods
02/20/1997CA2228999A1 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
02/20/1997CA2227204A1 Human mp52 arg protein
02/19/1997EP0758655A1 Process for the inactivation of carboxypeptidase Y in hirudin-containing culture broth
02/19/1997EP0758396A1 Feline immunodeficiency virus vaccine
02/19/1997EP0758394A1 Bifunctional protein, preparation and use
02/19/1997EP0758393A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
02/19/1997EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis
02/19/1997EP0758385A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens
02/19/1997EP0758384A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof
02/19/1997EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
02/19/1997EP0758381A1 Biologically active eph family ligands
02/19/1997EP0758379A1 Use of a thermostable enzyme as a feed additive
02/19/1997EP0758378A1 Thermostable xylanases